3 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 2 | Unknown 2 |
Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies CN202 - Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | Unknown | Curon Biopharmaceutical (Australia) Co Pty Ltd | 164 | 2021-10-22 | 2021-08-31 |
| Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation ramosetron - Hematologic Malignancies | Phase 2 | Unknown | The Catholic University of Korea | 65 | 2014-08-01 | 2014-12-08 |
| Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC) - Hematologic Malignancies | Phase 1 / Phase 2 | Unknown | A.O. Ospedale Papa Giovanni XXIII | 47 | 2013-09-01 | 2019-01-18 |
Hematologic Neoplasms (3) · Neoplasm Metastasis (1) · Vomiting (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Pathological Conditions, Signs and Symptoms (2) · Neoplastic Processes (1) · Pathologic Processes (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
ramosetron (1)
A.O. Ospedale Papa Giovanni XXIII (1) · Curon Biopharmaceutical (Australia) Co Pty Ltd (1) · The Catholic University of Korea (1)
Italy (1) · South Korea (1)
Alessandro Rambaldi, MD (1) · Gary Richardson (1) · Morteza Aghmesheh (1)
PMID 16732175, PMID 18468541, PMID 18703664, PMID 18820709, PMID 20350611, PMID 21393326, PMID 21417678